化合物 T10937 T10937

Product Introduction
Bioactivity


英文名: D-JNKI-1

描述: D-JNKI-1 (AM-111) is a highly effective and cell-permeable peptide inhibitor.

体外活性: D-JNKI-1 (AM-111; 1μM-1mM) treatment can prevent neomycin-exposed hair cell apoptosis and loss.

体内活性: D-JNKI-1 (AM-111; 10μM) can prevent almost all hair cell death and permanent hearing loss caused by neomycin ototoxicity in guinea pig cochlea mp. Local delivery of D-JNKI-1 can also prevent permanent hearing loss caused by hearing trauma in a dose-dependent manner. D-JNKI-1 (0.3 mg / kg, intraperitoneal injection) reversed these pathological events in the rat brain mitochondria, almost completely eliminating the release of cytochrome c and the cleavage of PARP. D-JNKI-1 (1 μg / kg, s.c.) caused a significant decrease in the disease activity index and reduced the expression of CD4 + and CD8 + cells in mice.

存储条件: keep away from moisturePowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: H2O : 50 mg/mL (13.08 mM)


关键字: D JNKI 1 | AM 111 | AM111 | D-JNKI-1 | XG102 | DJNKI1 | XG 102

相关产品: Lappaol F | JNK-1-IN-2 | Ganoderic acid X | beta-Asarone | Astragaloside IV | Decursinol angelate | (-)-Bornyl acetate | Desoxo-narchinol A | Vacquinol-1 | Arjunolic acid

化合物 T10937 T10937信息由TargetMol中国为您提供，如您想了解更多关于化合物 T10937 T10937报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途